Polymeric nanoparticles for hemoglobin-based oxygen carriers

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1784, Issue 10, 2008, Pages 1454-1461

  Piras, Anna Maria ^a   Dessy, Alberto ^a   Chiellini, Federica ^a   Chiellini, Emo ^a   Farina, Claudio ^b   Ramelli, Massimiliano ^c   Della Valle, Elena ^c  

^a UNIVERSITY OF PISA   (Italy)

^b Kedrion SpA   (Italy)

^c S Antimo (NA)   (Italy)

Author keywords

Bioerodible polymeric nanoparticle; Blood substitute; Hemoglobin based oxygen carrier

Indexed keywords

BLOOD SUBSTITUTE; COPOLYMER; HEMOGLOBIN BASED OXYGEN CARRIER; LIPOSOME; METHEMOGLOBIN; NANOPARTICLE; POLY(MALEIC ANHYDRIDE CO BUTYLVINYL ETHER); POLYMER; RECOMBINANT HEMOGLOBIN; UNCLASSIFIED DRUG;

CROSS LINKING; DRUG SYNTHESIS; ENCAPSULATION; HOMEOSTASIS; HUMAN; LIPID VESICLE; NONHUMAN; OXYGEN AFFINITY; OXYGEN TRANSPORT; POLYMERIZATION; PRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REVIEW;

ADULT; AGING; ANIMALS; BIOPOLYMERS; BLOOD SUBSTITUTES; DRUG CARRIERS; ERYTHROCYTES; FETAL BLOOD; HEMOGLOBINS; HUMANS; INFANT, NEWBORN; METHEMOGLOBIN; MODELS, ANIMAL; NANOPARTICLES; OXYGEN; OXYHEMOGLOBINS;

EID: 52049092981     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2008.03.013     Document Type: Review

References (111)

1. Vanderlinde E.S., Heal J.M., and Blumberg N. Autologous transfusion. BMJ 324 (2002) 772-775
2. Rao S.M. Blood conservation - How practical?. Indian J. Anaesth. 46 (2002) 168-174
3. Pape A. Alternatives to allogeneic blood transfusions. Best Pract. Res. Clin. Anaesthesiol. 21 (2007) 221-239
4. Chang T.M.S. Blood Substitutes: Principles, Methods, Products and Clinical Trials vol. 1 (1997), Karger-Landes-Systems publisher, Basel
5. Sakai H., Yuasa M., Onuma H., Takeoka S., and Tsuchida E. Synthesis and physicochemical characterization of a series of hemoglobin-based oxygen carriers: objective comparison between cellular and acellular types. Bioconjug. Chem. 11 (2000) 56-64
6. Ness P.M., and Cushing M.M. Oxygen therapeutics pursuit of an alternative to the donor red blood cell. Arch. Pathol. Lab. Med. 131 (2007) 734-741
7. Cothren C.C., Moore E.E., Long J.S., Haenel J.B., Johnson J.L., and Ciesla D.J. Large volume polymerized haemoglobin solution in a Jehovah's Witness following abruptio placenta. Tranfus. Med. 14 (2004) 241-246
8. Yu M., Dai M., Liu Q., and Xiu R. Laboratory-Clinica Interface: oxygen carriers and cancer chemo- and radiotherapy sensitization: bench to bedside and back. Cancer Treat. Rev. 33 (2007) 757-761
9. Alayash A.I. Oxygen therapeutics: can we tame hemoglobin?. Nature 3 (2004) 152-159
10. Fantoni A., Farace M.G., and Gambari R. Embryonic hemoglobins in man and other mammals. Blood 57 (1981) 623-633
11. Monod J., Wyman J., and Changeux J.P. On the nature of allosteric transitions: a plausible model. J. Mol. Biol. 12 (1965) 88-118
12. Lukin J.A., and Ho C. The structure-function relationship of hemoglobin in solution at atomic resolution. Chem. Rev. 104 (2004) 1219-1230
13. Hill A.V. The possible effects of the aggregation of the molecules of haemoglobin on its oxygen dissociation curve. J. Physiol. (Lond.) 40 (1910) IV-VII
14. Shikama K., and Matsuoka A. Human haemoglobin. A new paradigm for oxygen binding involving two types of ab contacts. Eur. J. Biochem. 270 (2003) 4041-4051
15. Rabiner S.F., O'Brien K., Peskin G.M., and Friedman L.H. Further studies on stroma-free hemoglobin solution. Ann. Surg. 171 (1970) 615-622
16. Remy B., Deby-Dupont G., and Lamy M. Red blood cell substitutes: fluorocarbon emulsions and hemoglobin solutions. British Med. Bull. 55 (1999) 277-298
17. Winslow R.M. Blood substitutes: refocusing an elusive goal. Br. J. Hematol. 111 (2000) 387-396
18. R.M. Winslow, Methods and compositions for optimization of oxygen transport by cell-free systems. US Patent 6, 054,427: The Regents of the University of California, (2000).
19. Winslow R.M. Targeted O2 delivery by low-p50 hemoglobin: a new basis for hemoglobin-based oxygen carriers. Artif. Cells Blood Substit. Immobil. Biotechnol. 33 (2005) 1-12
20. Stowell C.P. Hemoglobin-based oxygen carriers. Curr. Opin. Hematol. 9 (2002) 537-543
21. Chang T.M.S. Hemoglobin-based red blood cell substitutes. Artif. Org. 28 (2004) 789-794
22. Clark Jr. L.C., and Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 152 (1966) 1755
23. Riess J.G. Oxygen carriers ('blood substitutes') Raion d'etre, chemistry, and some physiology. Chem. Rev. 101 (2001) 2797-2894
24. Chatterjee R., Welty E.V., Walder R.Y., Pruitt S.L., Rogers S.L., Arnone A., and Walder J.A. Isolation and characterization of a new hemoglobin derivative cross-linked between the alfa chains (lysine 99 alfa 1-lysine 99 alfa 2). J. Biol.Chem. 261 (1986) 9929-9937
25. Przybelski R.J., Daily E.K., and Birnbaum M.L. The pressor effect of hemoglobin - good or bad?. In: Winslow R.M., Vandegriff K.D., and Intaglietta M. (Eds). Advances in Blood Substitutes: Industrial Opportunities and Medical Challenges (1997), Birkhauser, Boston
26. Kasper S.M., Walter M., Grune F., Bischoff A., Erasmi H., and Buzello W. Effect of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Cardiovasc. Anesth. 83 (1996) 921-927
27. Gould S.A., Moore E.E., Hoyt D.B., Burch J.M., Haenel J.B., Garcia J., DeWoskin R., and Moss G.S. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergency surgery. J. Am. Coll. Surg. 187 (1998) 113-122
28. 2 carrier. Artif. Organs Today 1 (1991) 89-114
29. 2 carrying solutions in vivo: preliminary results in the rabbit aorta. Artif. Cells Blood Substit. Immobil. Biotechnol. 26 (1998) 293-308
30. Murray J.A., Ledlow A., Launspach J., Evans D., Loveday M., and Conklin J.L. The effects of recombinant human hemoglobin on esophageal motor function in humans. Gastroenterology 109 (1995) 1241-1248
31. Lévy M.C., Rambourg P., Lévy J., and Potron G. Micro-encapsulation IV: cross-linked hemoglobin microcapsules. J. Pharm. Sci. 71 (1982) 759-762
32. Colombo M.F., Rau D.C., and Parsegian A.A. Protein solvation in allosteric regulation: a water effect. Science 256 (1992) 655-659
33. Nagababu E., Somasundaran R., Rifkind J.M., Jia Y., and Alayash A.I. Site-specific crosslinking of human and bovine hemoglobins differentially alters oxygen binding and redox side reaction producing rhombic heme and heme degradation. Biochemistry 41 (2002) 7407-7415
34. Moncada S., Palmer R.M.J., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-131
35. Abassi Z., Kotob S., Pieruzzi F., Abouassali M., Keiser H.R., Fratantoni J.C., and Alayash A.I. Effect of polymerization on the hypertensive action of diaspirin crosslinked hemoglobin in rats. J. Lab. Clin. Med. 129 (1997) 603-610
36. Doherty D.H., Doyle M.P., Curry S.R., Vali R.J., Fattor T.J., S Olsen J., and Lemon D.D. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat. Biotechnol. 1 (1998) 672-676
37. Saxena R., Wijnhoud A.D., Carton H., Hacke W., Kaste M., Przybelski R.J., Stern K.N., and Koudstaal P.J. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 30 (1999) 993-996
38. Hu T., Manjula B.N., Li D., Brenowitz M., and Acharya S.A. Influence of intramolecular cross-links on the molecular, structural and functional properties of PEGylated haemoglobin. Biochem. J. 402 (2007) 143-151
39. Rohlfs R.J., Bruner E., Chiu A., Gonzales A., Gonzales M.L., Magde M.D., Vandegriff K.D., and Winslow R.M. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J. Biol. Chem. 273 (1998) 12128-12134
40. Winslow R.M., Gonzales A., Gonzales M.L., Magde M., McCarthy M., Rohlfs J.R., and Vandegriff K.D. Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. J. Appl. Physiol. 85 (1998) 993-1003
41. Tsai A.G., Friesenecker B., and McCarthy M. Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skinfold model. Am. J. Physiol. 275 (1998) H2170-H2180
42. Li D., Manjula B.N., and Acharya A.S. Extension arm facilitated PEGylation of hemoglobin: correlation of the properties with the extent of PEGylation. Protein J. 25 4 (2006)
43. Asanuma H., Nakai K., Sanada S., Minamino T., Takashima S., Ogita H., Fujita M., Hirata A., Wakeno M., Takahama H., Kim J., Asakura M., Sakuma I., Kitabatake A., Hori M., Komamura K., and Kitakaze M. S-nitrosylated and pegylated hemoglobin, a newly developed artificial oxygen carrier, exerts cardioprotection against ischemic hearts. J. Mol. Cell. Cardiol. 42 (2007) 924-930
44. McCarthy M.R., Vandegriff K.D., and Winslow R.M. The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carrier. Biophys. Chem. 92 (2001) 103-117
45. Acharya A.S., Intaglietta M., Tsai A.G., Malavalli A., Vandegriff K., Winslow R.M., Smith P.K., Friedman J.M., and Manjula B.N. Enhanced molecular volume of conservatively pegylated Hb: (SP-PEG5K)6-HbA is non-hypertensive. Artif. Cells Blood Substit. Biotechnol. 33 (2005) 239-255
46. Veronese F.M. Peptide and protein pegylation: a review of problems and solution. Biomaterials 22 (2001) 405-417
47. Manjula B.N., Tsai A.G., Intaglietta M., Tsai C.H., Ho C., Smith P.K., Perumalsamy K., Kanika N.D., Friedman J.M., and Acharya S.A. Conjugation of multiple copies of polyethylene glycol to hemoglobin facilitated through thiolation: influence on hemoglobin structure and function. Protein J. 24 3 (2005)
48. Hu T., Prabhakaran M., Acharya S.A., and Manjula B.N. Influence of conjugation of poly(ethylene glycol) to Hb on the oxygen-binding and solution properties of the peg-hb conjugate. Biochem. J. 392 (2005) 555-564
49. Iafelice R., Cristoni S., Caccia D., Russo R., Rossi-Bernardi L., Lowe K.C., and Perrella M. Free in PMC identification of the sites of deoxyhaemoglobin PEGylation. Biochem. J. 403 (2007) 189-196
50. Manjula B.N., Tsai A., Upadhya R., Perumalsamy K., Smith P.K., Malavallil A., Vandergriff K., and Winslow R.M. Site-specific PEGylation of hemoglobin at Cys-93(β): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain. Bioconjug. Chem. 14 (2003) 464-472
51. Fournier R.L. Basic Transport Phenomena in Biomedical Engineering (1999), Taylor & Francis, Philadelphia
52. Wright R.O., Magnani B., W Shannon M., and Woolf A.D. N-Acetylcysteine reduces methemoglobin in vitro. Ann. Emerg. Med. 28 (1996) 499-503
53. Goorha Brig Y.K., Deb M.P., Chatterjee L.C.T., Dhot C.P., and Prasad B.R. Artifical blood. Med. J. Armed Forces India (MJAFI) 59 (2003) 45-50
54. Philips W.T., Klpper R.W., and Awasthi V.D. Polyethylene glyco-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute. J. Pharm. Exp. Therapeutics 288 (1999) 665-670
55. Abugo O.O., Balagopalakrishna C., Rifkind J.M., Rudolph A.S., Hess J.R., and Macdonald V.W. Direct measurements of hemoglobin interactions with liposomes using EPR spectroscopy. Artif. Cells Blood Substit. Immobil. Biotechnol. 29 (2001) 5-18
56. Arifin D.R., and Palmer A.F. Determination of size distribution and encapsulation efficiency of liposome-encapsulated hemoglobin blood substitutes using asymmetric flow field-flow fractionation coupled with multi-angle static light scattering. Biotechnol. Prog. 19 (2003) 1798-1811
57. Meng F.T., Ma G.H., Liu Y.D., Qiu W., and Su Z.G. Microencapsulation of bovine hemoglobin with high bio-activity and high entrapment efficiency using a W/O/W double emulsion technique. Colloids surf., B Biointerfaces 33 (2004) 177-183
58. Arifin D.R., and Palmer A.F. Polymersome encapsulated hemoglobin: a novel type of oxygen carrier. Biomacromolecules 6 (2005) 2172-2181
59. Chang T.M.S. Future prospects for artificial blood. Trends Biotechnol. 17 (1999) 61-67
60. Tsuchida E., Sakai H., Horinouchi H., and Kobayashi K. Hemoglobin-vesicles as a transfusion alternative. Artif. cells blood substit. biotechnol. 34 (2006) 581-588
61. Ogata Y. Evaluation of human hemoglobin vesicle as an oxygen carrier: recovery from hemorrhagic shock in rabbits. Polym. Adv. Technol. 11 (2000) 301-306
62. Yoshizu A., Izumi Y., Park S., Sakai H., Takeoka S., Horinouchi H., Ikeda E., Tsuchida E., and Kobayashi K. Hemorrhagic shock resuscitation with an artificial oxygen carrier, hemoglobin vesicle, maintains intestinal perfusion and suppresses the increase in plasma tumor necrosis factor-α. ASAIO J. 50 (2004) 458-463
63. Contaldo C., Plock J., Sakai H., Takeoka S., Tsuchida E., Leunig M., Banic A., and Erni D. New generation of hemoglobin-based oxygen carriers evaluated for oxygenation of critically ischemic hamster flap tissue. Crit. Care Med. 33 (2005) 806-812
64. Awasthi V.D., Garcia D., Klipper R., Goins B.A., and Phillips W.T. Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics. J. Pharmacol. Exp. Ther. 309 (2004) 241-248
65. Awasthi V.D., Garcia D., Klipper R., Phillips W.T., and Goins B.A. Kinetics of liposome-encapsulated hemoglobin after 25% hypovolemic exchange transfusion. Int. J. Pharmaceutics 283 (2004) 53-62
66. Sakai H., Horinouchi H., Masada Y., Takeoka S., Ikeda E., Takaori M., Kobayashi K., and Tsuchida E. Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model. Biomaterials 25 (2004) 4317-4325
67. Schnitzer E., Pinchuk I., and Lichtenberg D. Peroxidation of liposomal lipids. Eur. Biophys. J. 36 (2007) 499-515
68. Szebeni J., Winterbourn C.C., and Carrell R.W. Oxidative interaction between haemoglobin and membrane lipid. A liposome Model. Biochem. J. 220 (1984) 685-692
69. Szebeni J., Di Iorio E.E., Hauser H., and Winterhalter K.H. Encapsulation of hemoglobin in phospholipid liposomes: characterization and stability. Biochemistry 24 (1985) 2827-2832
70. Sakai H., Tomiyama K., Sou K., Takeoka S., and Tsuchida E. Poly(ethylene glycol)-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state. Bioconjug. Chem. 11 (2000) 425-432
71. Buehler P.W., and Alayash A.I. Toxicities of hemoglobin solutions: in search of in vitro and in-vivo model systems. Transfusion 44 (2004) 1516-1530
72. Antonietti M., and Förster S. Vesicles and liposomes: a self-assembly principle beyond lipids. Adv. Mater. 15 (2003) 1323-1333
73. Moghimi S.M., and Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 42 (2003) 463-478
74. Abe H., Azuma H., Yamaguchi M., Fujihara M., Ikeda H., Sakai H., Takeoka S., and Tsuchida E. Effects of hemoglobin vesicles, a liposomal artificial oxygen carrier, on hematological responses, complement and anaphylactic reactions in rats. Artf. Cells Blood Substit. Immobil. Biotechnol. 35 (2007) 157-172
75. Sakai H., Sou K., Horinouchi H., Kobayashi K., and Tsuchida E. Haemoglobin-vesicles as artificial oxygen carriers: present situation and future visions. J. Intern. Med. 263 (2008) 4-15
76. Chauvierre C., Marden M.C., Vauthier C., Labarre D., Couvreur P., and Leclerc L. Heparin coated poly(alkylcyanoacrylate) nanoparticles coupled to hemoglobin: a new oxygen carrier. Biomaterials 25 (2004) 3081-3086
77. Zhao J., Liua C., Yuan Y., Tao X., Shan X., Sheng Y., and Wu F. Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers. Biomaterials 28 (2007) 1414-1422
78. Yu W.P., and Chang T.M. Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization. Artif. Cells Blood Substit. Immobil. Biotechnol. 24 (1996) 169-183
79. Chang T.M.S. A new red blood cell substitute. Crit. Care Med. 32 (2004) 612-613
80. Patton J.N., and Palmer A.F. Engineering temperature-sensitive hydrogel nanoparticles entrapping hemoglobin as a novel type of oxygen carrier. Biomacromolecules 6 (2005) 2204-2212
81. El-Gibaly I., and Anwar M. Hemolysate-filled polyethyleneimine and polyurea microcapsules as potential red blood cell substitutes: effect of aqueous monomer type on properties of the prepared microcapsules. Int. J. Pharm. 27 (2004) 25-40
82. Patton J.N., and Palmer A.F. Physical properties of hemoglobin-poly(acrylamide) hydrogel-based oxygen carriers: effect of reaction pH. Langmuir 22 (2006) 2212-2221
83. Sugawara Y., Kadono E., Suzuki A., Yukuta Y., Shibasaki Y., Nishimura N., Kameyama Y., Hirota M., Ishida C., Higuchi N., Haramoto K., Sakai Y., and Soda H. Hemichrome formation observed in human haemoglobin A under various buffer conditions. Acta Physiol. Scand. 179 (2003) 49-59
84. Hrinczenkoa B.W., Schechtera A.N., Wojtkowskia T.L., Pannella L.K., Cashonb R.E., and Alayash A.I. Nitric oxide-mediated heme oxidation and selective β-globin nitrosation of hemoglobin from normal and sickle erythrocytes. Biochem. Biophys. Res. Commun. 275 (2000) 962-967
85. Szebeni J., and Toth K. Lipid-peroxidation in hemoglobin-containing liposomes - effects of membrane phospholipid-composition and cholesterol content. Biochim. Biophys. Acta 857 (1986) 139-145
86. Abe K., and Sugita Y. Properties of cytochrome b5 and methemoglobin reduction in human erythrocytes. Eur. J. Biochem. 101 (1979) 423-428
87. Sakai H., Takeoka S., Seino Y., Nishide H., and Tuschida E. Purification of concentrated hemoglobin using organic solvent and heat treatment protein. Expr. Purif. 4 (1993) 563-569
88. Chang T.M.S. Hemoglobin Corpuscles. Report of a research project for Honours Physiology, Medical Library, McGill University, 1957. Also reprinted as part of "30th anniversary in Artificial Red Blood Cells Research". Biomater. Artif. Cells 16 (1988) 1-9
89. Chang T.M.S., D'Agnillo F., Yu W.P., and Razack S. Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation. Adv. drug deliv. rev. 40 (2000) 213-218
90. T.M.S. Chang, D. Powanda, W.P. Yu, Biodegradable polymeric nanocapsules and uses thereof (2002) PCT/CA2002/001331-WO/2003/017987 (2003).
91. Teramura Y., Kanazawa H., Sakai H., Takeoka S., and Tsuchida E. Prolonged oxygen-carrying ability of hemoglobin vesicles by coencapsulation of catalane in vivo. Bioconjug. Chem. 14 (2003) 1171-1176
92. Sakai H., Takeoka S., Seino Y., and Tsuchida E. Suppression of methemoglobin formation by glutathione in a concetrated hemoglobin solution and in a hemoglobin-vesicle. Bull. Chem. Soc. Jpn. 67 (1994) 1120-1125
93. Takeoka S., Sakai H., Kose T., Mano Y., Seino Y., Nishide H., and Tsuchida E. Methemoglobin formation in hemoglobin vesicles and reduction by encapsulated thiols. Bioconjug. Chem. 8 (1997) 539-544
94. Patton J.N., and F Palmer A. Photopolymerization of bovine hemoglobin entrapped nanoscale hydrogel particles within liposomal reactors for use as an artificial blood substitute. Biomacromolecules 6 (2005) 414-424
95. Atoji T., Aihara M., Sakai H., Tsuchida E., and Takeoka S. Hemoglobin vesicles containing methemoglobin and l-tyrosine to suppress methemoglobin formation in vitro and in vivo. Bioconjug. Chem. 17 (2006) 1241-1245
96. Akama K., Gong W.-L., Wang L., Tokuyama S., and Tsuchida E. Stable preservation of hemoglobin vesicles as a blood substitute. Polym. Adv. Technol. 10 (1999) 293-298
97. Chiellini E., Solaro R., Leonardi G., Giannasi D., Lisciani R., and Mazzanti G. New polymeric hydrogel formulations for the controlled release of a-interferon. J. Control. Release 22 (1992) 273-282
98. Piras A.M., Nikkola L., Chiellini F., Ashammakhi N., and Chiellini E. Development of diclofenac sodium releasing bio-erodible polymeric nanomats. J. Nanosci. Nanotechnol. 6 (2006) 3310-3320
99. Chiellini E.E., Chiellini F., and Solaro R. Bioerodible polymeric nanoparticles for targeted delivery of proteic drugs. J. Nanosci. Nanotechnol. 6 (2006) 3040-3047
100. Woodruff C.W., Peck G.E., and Banker G.S. Dissolution of alkyl vinyl ether-maleic anhydride copolymers and ester derivatives. J. Pharm. Sci. 61 (1972) 1912-1916
101. Heller J., W Baker R., Gale R.M., and Rodin J.O.J. Appl. Polym. Sci. 22 (1978) 1991-2009
102. Chiellini E., Leonardi G., Giannasi D., and Solaro R. J. Bioact. Compat. Polym. 7 (1992) 161-174
103. F. Chiellini, A.M. Piras, M. Gazzarri, C. Bartoli, M. Ferri, L. Paolini. Bioactive polymeric materials for targeted administration of active agents - synthesis and evaluation. Macromol. Biosci. (in press), doi:10.1002/mabi.200700228.
104. J. Cowdall, J. Davies, M. Roberts, A Carlsson, R. Solaro, G. Mazzanti, E.E. Chiellini, E. Söderlind, Microparticles based on hybrid polymeric materials for controlled release of biologically active molecules, a process for preparing the same and their uses for in vivo and in vitro therapy, prophylaxis and diagnostics (1998) PCT/1998/000191 - EP 1 001 744 B1 (2005).
105. J. Cowdall, J. Davies, M. Roberts, A Carlsson, R. Solaro, G. Mazzanti, E.E. Chiellini, F. Chiellini, E. Söderlind, Microparticles for controlled delivery of biologically active molecules (1998) PCT/IT1998/000192 - EP 1 003 482 B1 (2005).
106. Chiellini E., Chiellini E.E., Chiellini F., and Solaro R. Targeted administration of proteic drugs. I. Preparation of polymeric nanoparticles. J. Bioact. Compat. Polym. 16 (2001) 441-465
107. Chiellini F., Bartoli C., Dinucci D., Piras A.M., Anderson R., and Croucher T. Bioeliminable polymeric nanoparticles for proteic drug delivery. Int. J. Pharm. 343 (2007) 90-97
108. Piras A.M., Chiellini F., Fiumi C., Bartoli C., and Chiellini E. A new biocompatible nanoparticle delivery system for the release of fibrinolytic drugs. Int. J. Pharm. 357 (2008) 260-271
109. Solaro R., Chiellini F., Signori F., Fiumi C., Bizzarri R., and Chiellini E. Nanoparticle systems for the targeted release of active principles of proteic nature. J. Mater. Sci., Mater. Med. 14 (2003) 705-711
110. Szejtli J. Cyclodextrins in pharmaceuticals. Cyclodextrin Technology (1988), Kluwer Academic Publishers, Dordrecht, The Netherlands 186-306
111. Rother R.P., Bell L., Hillmen P., and Gladwin M.T. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin. A novel mechanism of human disease. JAMA 293 (2005) 1653-1662